Skip to content

Effect of Yellow Pea Protein and Fibre Added to a High-carb Meal on Glycemic Response and Food Intake

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02015429
Enrollment
15
Registered
2013-12-19
Start date
2007-12-31
Completion date
2008-12-31
Last updated
2013-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Obesity

Keywords

Food intake, satiety, glycemia, appetite, blood glucose, yellow peas, fibre, protein, mixed meal

Brief summary

The investigators hypothesized that consuming isolated yellow pea fibre or protein, alone to together, as part of a high-carbohydrate pasta meal, would reduce the blood glucose response to the meal compared to a meal without yellow pea components and reduce food intake at a meal served 2 hours later.

Interventions

DIETARY_SUPPLEMENTPasta meal with added fractions or control with no fractions

Sponsors

University of Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
20 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Non-smoking * No metabolic disease * BMI 20 - 25 kg/m\^2 * male * age 20-30

Exclusion criteria

* Intolerance to treatments * on appetite-modifying medications * restrictive eating * smoking * over or underweight * breakfast-skipping

Design outcomes

Primary

MeasureTime frameDescription
Ad libitum food intake at second pizza meal135 mins after completion of treatment, 20 mins to eat pizza meal.Food intake measured via electronic scale in g, then converted to kcal using the caloric density.
Blood glucosebetween 0 and 215 mins, every 15-30 minsBlood glucose measured via hand-held glucometer and finger prick.

Secondary

MeasureTime frameDescription
Subjective appetite0 to 215 minutesMeasured via Visual Analog Scales (VAS)

Other

MeasureTime frameDescription
Palatability of treatmentsfollowing treatment consumption at 15 minsMeasured by VAS to ensure palatability is not confounding other outcomes.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026